help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lowe, G. N.
Right arrow Articles by Hahn, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lowe, G. N.
Right arrow Articles by Hahn, T. J.

Endocrinology, Vol 137, 2208-2216, Copyright © 1996 by Endocrine Society


ARTICLES

Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthesis in the RCJ 3.1C5.18 chondrocyte cell line: role of second messengers

GN Lowe, YH Fu, S McDougall, R Polendo, A Williams, PD Benya and TJ Hahn
Department of Medicine, West Los Angeles Veterans Administration Medical Center, California 90073, USA.

PGs play an important role in regulating articular chondrocyte function in both normal and pathological states. However, the mechanisms of the effects of PG on chondrocyte function remain undefined. We, therefore, examined the effects of PGE1, PGE2, and PGE2 alpha on second messenger generation in relation to DNA and aggrecan synthesis in the nontransformed rat RCJ 3.1C5.18 (RCJ) chondrocyte cell line. RCJ cells were grown under minimal attachment conditions on a composite collagen- agarose (0.15%/0.8%) gel to maintain a differentiated phenotype. PGE1 and PGE2 (0.001-100 microM) produced a similar dose-related increase in cAMP accumulation, with a maximal 8-fold increase over basal values, whereas PGF2 alpha produced a minimal 1.3-fold increase in cAMP levels only at 100 microM. On the other hand, both PGE2 and PGE2 alpha raised the intracellular free calcium ([Ca2+]i) concentration, derived primarily from extracellular sources, whereas PGE1 was without effect on [Ca2+]i. These three PGs also had divergent effects on DNA synthesis, as measured by [3H]thymidine ([3H]TdR) incorporation. PGF2 alpha (0.001-5 microM) produced a dose-related increase in [3H]TdR incorporation, with a maximal 1.6-fold increase over baseline values at 5 microM and a slight decline to below maximal levels at 10 microM. PGE2 exhibited a contrasting inverse biphasic response, with an initial small suppressive effect that was maximal at 0.1 microM and a secondary stimulatory phase producing a small increase over control values at 5 microM. PGE1 had a uniformly suppressive effect, producing a 30% decrease at 10 microM. Despite the divergent effects of PGE1, PGE2, and PGE2 alpha on second messenger generation and DNA synthesis, all three PGs produced a dose-related stimulation of aggrecan synthesis. PGF2 alpha was the most potent, producing significant stimulation at 0.001 microM and a maximal 104% increase at 5 microM. PGE1 and PGE2 were approximately equipotent and approximately 60% as effective as PGF2 alpha in stimulating aggrecan synthesis. Northern analysis demonstrated that the effects of PG on aggrecan synthesis were not accompanied by changes in aggrecan core protein steady state messenger RNA levels. Thus, the effects of PG on aggrecan production in RCJ cells appear to be regulated at the posttranscriptional level. Forskolin and (Bu)2cAMP mimicked the suppressive effects of PGE1 on [3H]TdR incorporation, as well as the stimulatory effect of PGE1 on aggrecan synthesis. In addition, the phorbol ester 12-O-tetradecanoyl phorbol acetate mimicked PGF2 alpha stimulation of [3H]TdR incorporation and aggrecan synthesis, and the effects of PGE2 alpha on these processes were blocked by protein kinase C inhibitors. Therefore, it appears that in mammalian chondrocytes, PGE1 primarily activates the cAMP-protein kinase A second messenger system, PGE2 alpha affects primarily the Ca2(+)-protein kinase C system, and PGE2 activates both pathways. Moreover, PG posttranscriptional regulation of aggrecan synthesis in chondrocytes involves both the cAMP-protein kinase A and Ca2(+)-protein kinase C second messenger systems.


This article has been cited by other articles:


Home page
JBJSHome page
A. M. Simon and J. P. O'Connor
Dose and Time-Dependent Effects of Cyclooxygenase-2 Inhibition on Fracture-Healing
J. Bone Joint Surg. Am., March 1, 2007; 89(3): 500 - 511.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Jakob, O. Demarteau, R. Suetterlin, M. Heberer, and I. Martin
Chondrogenesis of expanded adult human articular chondrocytes is enhanced by specific prostaglandins
Rheumatology, July 1, 2004; 43(7): 852 - 857.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. B. Fitzgerald, M. Jin, D. Dean, D. J. Wood, M. H. Zheng, and A. J. Grodzinsky
Mechanical Compression of Cartilage Explants Induces Multiple Time-dependent Gene Expression Patterns and Involves Intracellular Calcium and Cyclic AMP
J. Biol. Chem., May 7, 2004; 279(19): 19502 - 19511.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. Abulencia, R. Gaspard, Z. R. Healy, W. A. Gaarde, J. Quackenbush, and K. Konstantopoulos
Shear-induced Cyclooxygenase-2 via a JNK2/c-Jun-dependent Pathway Regulates Prostaglandin Receptor Expression in Chondrocytic Cells
J. Biol. Chem., August 1, 2003; 278(31): 28388 - 28394.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Patel, M. G. Attur, M. Dave, S. B. Abramson, and A. R. Amin
Regulation of Cytosolic COX-2 and Prostaglandin E2 Production by Nitric Oxide in Activated Murine Macrophages
J. Immunol., April 1, 1999; 162(7): 4191 - 4197.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
G. P. Lunstrum, D. R. Keene, N. B. Weksler, Y.-J. Cho, M. Cornwall, and W. A. Horton
Chondrocyte Differentiation in a Rat Mesenchymal Cell Line
J. Histochem. Cytochem., January 1, 1999; 47(1): 1 - 6.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. P. Schick, I. Petrushina, K. C. Brodbeck, and P. Castronuevo
Promoter Regulatory Elements and DNase I-hypersensitive Sites Involved in Serglycin Proteoglycan Gene Expression in Human Erythroleukemia, CHRF 288-11, and HL-60 Cells
J. Biol. Chem., June 29, 2001; 276(27): 24726 - 24735.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society